The Latest
FDA Extends Review Period for Gene Therapies for Beta-Thalassemia, Cerebral Adrenoleukodystrophy
Cibinqo Approved for Refractory, Moderate to Severe Atopic Dermatitis
Rinvoq Gains FDA Approval for Atopic Dermatitis
Influenza Vaccination Cuts Risk of Critical Illness in Children
Secondhand Vape Exposure Linked to Respiratory Symptoms
Fosfomycin Not Noninferior to Comparators for Bacteremic UTI
WHO Living Guideline Updated for Drug Treatment of COVID-19
NCCN Endorses Full COVID-19 Vaccination for Cancer Patients
Comprehensive Approach Advised for Managing CV Risk in T2DM
MPR ARTICLES
